Literature DB >> 28182568

Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.

Nicolas Veziris1,2, Christine Bernard3,2, Lorenzo Guglielmetti3,2,4, Damien Le Du4, Dhiba Marigot-Outtandy4,5, Marie Jaspard6, Eric Caumes6, Isabelle Lerat7, Christophe Rioux7, Yazdan Yazdanpanah7,8,9, Angelica Tiotiu10, Nadine Lemaitre11, Florence Brossier3,2, Vincent Jarlier3,2, Jerome Robert3,2, Wladimir Sougakoff3,2, Alexandra Aubry3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28182568     DOI： 10.1183/13993003.01719-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  21 in total

1.  Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.

Authors:  Suha Kadura; Nicholas King; Maria Nakhoul; Hongya Zhu; Grant Theron; Claudio U Köser; Maha Farhat
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

2.  Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.

Authors:  S Battaglia; A Spitaleri; A M Cabibbe; C J Meehan; C Utpatel; N Ismail; S Tahseen; A Skrahina; N Alikhanova; S M Mostofa Kamal; A Barbova; S Niemann; R Groenheit; A S Dean; M Zignol; L Rigouts; D M Cirillo
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

3.  Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis.

Authors:  Qinglong Guo; Jing Bi; Qiao Lin; Taosheng Ye; Zhongyuan Wang; Zhaoqin Wang; Lei Liu; Guoliang Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-05-27       Impact factor: 6.073

Review 4.  Bedaquiline: Fallible Hope Against Drug Resistant Tuberculosis.

Authors:  Priya Singh; Rashmi Kumari; Rup Lal
Journal:  Indian J Microbiol       Date:  2017-10-24       Impact factor: 2.461

5.  Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.

Authors:  Keira A Cohen; Katharine E Stott; Vanisha Munsamy; Abigail L Manson; Ashlee M Earl; Alexander S Pym
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

6.  Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.

Authors:  Devyani Deshpande; Shashikant Srivastava; Paula Bendet; Katherine R Martin; Kayle N Cirrincione; Pooi S Lee; Jotam G Pasipanodya; Keertan Dheda; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 7.  Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.

Authors:  Navisha Dookie; Santhuri Rambaran; Nesri Padayatchi; Sharana Mahomed; Kogieleum Naidoo
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

8.  Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study.

Authors:  Nazir A Ismail; Shaheed V Omar; Lavania Joseph; Netricia Govender; Linsay Blows; Farzana Ismail; Hendrik Koornhof; Andries W Dreyer; Koné Kaniga; Norbert Ndjeka
Journal:  EBioMedicine       Date:  2018-01-09       Impact factor: 8.143

9.  Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.

Authors:  Elsje Pienaar; Jennifer J Linderman; Denise E Kirschner
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

10.  Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis.

Authors:  N Ismail; S V Omar; N A Ismail; R P H Peters
Journal:  Data Brief       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.